brolucizumab-dbll
Brand: BEOVU
approved
Quick answer
brolucizumab-dbll (BEOVU), is a pharmaceutical active ingredient, with approved status in the US.
Key facts
- INN
- brolucizumab-dbll
- Brand
- BEOVU
- Route
- INTRAVITREAL
- Formulation
- INJECTABLE
Frequently asked questions
What is brolucizumab-dbll?
brolucizumab-dbll (BEOVU), is a pharmaceutical active ingredient, with approved status in the US.
What is the brand name for brolucizumab-dbll?
BEOVU is a marketed brand name for brolucizumab-dbll. Check FDA Drugs@FDA for the current US label holder.